Evolving anatomic, functional, and molecular imaging in the early detection and prognosis of hypertrophic cardiomyopathy

Journal of Cardiovascular Translational Research

Volumn 2, Issue 4, 2009, Pages 398-406

  Fuster, Valentin ^a,b   Van Der Zee, Sarina ^a   Miller, Marc A ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b CENTRO NACIONAL DE INVESTIGACIONES CARDIOVASCULARES CNIC   (Spain)

Author keywords

Cardiac Magnetic Resonance Imaging; Echocardiography; Hypertrophic Cardiomyopathy

Indexed keywords

ADENOSINE TRIPHOSPHATE; CREATINE PHOSPHATE;

CLINICAL ASSESSMENT; CONGESTIVE HEART FAILURE; DIAGNOSTIC IMAGING; DIFFERENTIAL DIAGNOSIS; EARLY DIAGNOSIS; ENERGY METABOLISM; FUNCTIONAL ASSESSMENT; HEART LEFT VENTRICLE HYPERTROPHY; HEART MUSCLE FIBROSIS; HEART MUSCLE METABOLISM; HIGH RISK PATIENT; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; MOLECULAR IMAGING; PRIORITY JOURNAL; PROGNOSIS; REVIEW; SENSITIVITY AND SPECIFICITY; SUDDEN DEATH; TISSUE DOPPLER IMAGING; CARDIOMYOPATHY, HYPERTROPHIC; COMPLICATION; DISEASE COURSE; DOPPLER ECHOCARDIOGRAPHY; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PREDICTIVE VALUE; PROCEDURES; SEVERITY OF ILLNESS INDEX;

CARDIOMYOPATHY, HYPERTROPHIC; DIAGNOSIS, DIFFERENTIAL; DIAGNOSTIC IMAGING; DISEASE PROGRESSION; EARLY DIAGNOSIS; ECHOCARDIOGRAPHY, DOPPLER; HUMANS; MAGNETIC RESONANCE IMAGING; MAGNETIC RESONANCE SPECTROSCOPY; MOLECULAR IMAGING; PREDICTIVE VALUE OF TESTS; PROGNOSIS; SEVERITY OF ILLNESS INDEX;

EID: 75949098315     PISSN: 19375387     EISSN: 19375395     Source Type: Journal    
DOI: 10.1007/s12265-009-9133-6     Document Type: Review

References (72)

1. BJ Maron JM Gardin JM Flack SS Gidding TT Kurosaki DE Bild 1995 Prevalence of hypertrophic cardiomyopathy in a general population of young adults. Echocardiographic analysis of 4111 subjects in the CARDIA Study. Coronary Artery Risk Development in (Young) Adults Circulation 92 785 789 1:STN:280:DyaK2MzmvVyisg%3D%3D 7641357
2. HG Klues A Schiffers BJ Maron 1995 Phenotypic spectrum and patterns of left ventricular hypertrophy in hypertrophic cardiomyopathy: Morphologic observations and significance as assessed by two-dimensional echocardiography in 600 patients Journal of the American College of Cardiology 26 1699 1708 10.1016/0735-1097(95)00390-8 1:STN:280:DyaK28%2FotlGntw%3D%3D 7594106
3. J Binder SR Ommen BJ Gersh, et al. 2006 Echocardiography-guided genetic testing in hypertrophic cardiomyopathy: Septal morphological features predict the presence of myofilament mutations Mayo Clinic Proceedings 81 459 467 10.4065/81.4.459 16610565
4. S Urheim T Edvardsen H Torp B Angelsen OA Smiseth 2000 Myocardial strain by Doppler echocardiography. Validation of a new method to quantify regional myocardial function Circulation 102 1158 1164 1:STN:280:DC%2BD3cvls1Klsw%3D%3D 10973846
5. NR Van de Veire J De Sutter JJ Bax JR Roelandt 2008 Technological advances in tissue Doppler imaging echocardiography Heart 94 1065 1074 10.1136/hrt.2007.120758 18230638 (Pubitemid 352039893)
6. GK Efthimiadis G Giannakoulas DG Parharidou, et al. 2006 Prevalence of systolic impairment in an unselected regional population with hypertrophic cardiomyopathy American Journal of Cardiology 98 1269 1272 10.1016/j.amjcard. 2006.05.063 17056344 (Pubitemid 44584119)
7. AT Burns IG McDonald JD Thomas A Macisaac D Prior 2008 Doin' the twist: New tools for an old concept of myocardial function Heart 94 978 983 10.1136/hrt.2007.120410 1:STN:280:DC%2BD1cvltVSgug%3D%3D 18625792 (Pubitemid 352039877)
8. JP Sun WJ Stewart XS Yang, et al. 2009 Differentiation of hypertrophic cardiomyopathy and cardiac amyloidosis from other causes of ventricular wall thickening by two-dimensional strain imaging echocardiography American Journal of Cardiology 103 411 415 10.1016/j.amjcard.2008.09.102 19166699
9. F Bayrak G Kahveci B Mutlu K Sonmez M Degertekin 2008 Tissue Doppler imaging to predict clinical course of patients with hypertrophic cardiomyopathy European Journal of Echocardiography 9 278 283 10.1093/ejechocard/jen049 18490324 (Pubitemid 351665204)
10. GC Nesbitt S Mankad JK Oh 2009 Strain imaging in echocardiography: Methods and clinical applications International Journal of Cardiovascular Imaging 25 Suppl 1 9 22 10.1007/s10554-008-9414-1 19145475
11. GS Soor A Luk E Ahn, et al. 2009 Hypertrophic cardiomyopathy: Current understanding and treatment objectives Journal of Clinical Pathology 62 226 235 10.1136/jcp.2008.061655 1:STN:280:DC%2BD1M7nt1Snuw%3D%3D 18930982
12. SF Nagueh J McFalls D Meyer, et al. 2003 Tissue Doppler imaging predicts the development of hypertrophic cardiomyopathy in subjects with subclinical disease Circulation 108 395 398 10.1161/01.CIR.0000084500.72232.8D 12860897 (Pubitemid 36935530)
13. SF Nagueh LL Bachinski D Meyer, et al. 2001 Tissue Doppler imaging consistently detects myocardial abnormalities in patients with hypertrophic cardiomyopathy and provides a novel means for an early diagnosis before and independently of hypertrophy Circulation 104 128 130 1:STN:280: DC%2BD3Mzpt1Kqsg%3D%3D 11447072
14. CY Ho NK Sweitzer B McDonough, et al. 2002 Assessment of diastolic function with Doppler tissue imaging to predict genotype in preclinical hypertrophic cardiomyopathy Circulation 105 2992 2997 10.1161/01.CIR.0000019070. 70491.6D 12081993 (Pubitemid 34693832)
15. M Michels OI Soliman MJ Kofflard, et al. 2009 Diastolic abnormalities as the first feature of hypertrophic cardiomyopathy in Dutch myosin-binding protein C founder mutations JACC Cardiovascular Imaging 2 58 64 10.1016/j.jcmg.2008.08. 003 19356534
16. A Buakhamsri ZB Popovic J Lin, et al. 2009 Impact of left ventricular volume/mass ratio on diastolic function European Heart Journal 30 1213 1221 10.1093/eurheartj/ehp084 19304742
17. P Richard P Charron L Carrier, et al. 2003 Hypertrophic cardiomyopathy: Distribution of disease genes, spectrum of mutations, and implications for a molecular diagnosis strategy Circulation 107 2227 2232 10.1161/01.CIR. 0000066323.15244.54 12707239 (Pubitemid 36547217)
18. T Kubo JR Gimeno A Bahl, et al. 2007 Prevalence, clinical significance, and genetic basis of hypertrophic cardiomyopathy with restrictive phenotype Journal of the American College of Cardiology 49 2419 2426 10.1016/j.jacc.2007. 02.061 1:CAS:528:DC%2BD2sXntFyhs78%3D 17599605 (Pubitemid 46962256)
19. J Du C Zhang J Liu C Sidky XP Huang 2006 A point mutation (R192H) in the C-terminus of human cardiac troponin I causes diastolic dysfunction in transgenic mice Archives of Biochemistry and Biophysics 456 143 150 10.1016/j.abb.2006.08.018 1:CAS:528:DC%2BD28XhtlaltLfJ 17027633 (Pubitemid 44880289)
20. JB Geske P Sorajja RA Nishimura SR Ommen 2007 Evaluation of left ventricular filling pressures by Doppler echocardiography in patients with hypertrophic cardiomyopathy: Correlation with direct left atrial pressure measurement at cardiac catheterization Circulation 116 2702 2708 10.1161/CIRCULATIONAHA.107.698985 18025528 (Pubitemid 350291242)
21. N Krasnow 1997 Subaortic septal bulge simulates hypertrophic cardiomyopathy by angulation of the septum with age, independent of focal hypertrophy. An echocardiographic study Journal of the American Society of Echocardiography 10 545 555 10.1016/S0894-7317(97)70009-9 1:STN:280: DyaK2szkslWgsw%3D%3D 9203495
22. A Chen-Tournoux MA Fifer MH Picard J Hung 2008 Use of tissue Doppler to distinguish discrete upper ventricular septal hypertrophy from obstructive hypertrophic cardiomyopathy American Journal of Cardiology 101 1498 1503 10.1016/j.amjcard.2008.01.027 18471465
23. D Vinereanu N Florescu N Sculthorpe AC Tweddel MR Stephens AG Fraser 2001 Differentiation between pathologic and physiologic left ventricular hypertrophy by tissue Doppler assessment of long-axis function in patients with hypertrophic cardiomyopathy or systemic hypertension and in athletes American Journal of Cardiology 88 53 58 10.1016/S0002-9149(01)01585-5 1:STN:280:DC%2BD3MzmtFClsQ%3D%3D 11423058 (Pubitemid 32553892)
24. K Shan RJ Bick BJ Poindexter, et al. 2000 Relation of tissue Doppler derived myocardial velocities to myocardial structure and beta-adrenergic receptor density in humans Journal of the American College of Cardiology 36 891 896 10.1016/S0735-1097(00)00786-5 1:STN:280:DC%2BD3cvlvV2mtQ%3D%3D 10987616 (Pubitemid 30681615)
25. H Yang JP Sun HM Lever, et al. 2003 Use of strain imaging in detecting segmental dysfunction in patients with hypertrophic cardiomyopathy Journal of the American Society of Echocardiography 16 233 239 10.1067/mje.2003.60 12618731 (Pubitemid 36397617)
26. SF Nagueh CP Appleton TC Gillebert, et al. 2009 Recommendations for the evaluation of left ventricular diastolic function by echocardiography Journal of the American Society of Echocardiography 22 107 133 10.1016/j.echo.2008.11.023 19187853
27. BM van Dalen F Kauer OI Soliman, et al. 2009 Influence of the pattern of hypertrophy on left ventricular twist in hypertrophic cardiomyopathy Heart 95 657 661 10.1136/hrt.2008.152777 18977803
28. NL Greenberg MS Firstenberg PL Castro, et al. 2002 Doppler-derived myocardial systolic strain rate is a strong index of left ventricular contractility Circulation 105 99 105 10.1161/hc0102.101396 11772883 (Pubitemid 34049149)
29. ZB Popovic DH Kwon M Mishra, et al. 2008 Association between regional ventricular function and myocardial fibrosis in hypertrophic cardiomyopathy assessed by speckle tracking echocardiography and delayed hyperenhancement magnetic resonance imaging Journal of the American Society of Echocardiography 21 1299 1305 10.1016/j.echo.2008.09.011 19041572
30. AS Adabag BJ Maron E Appelbaum, et al. 2008 Occurrence and frequency of arrhythmias in hypertrophic cardiomyopathy in relation to delayed enhancement on cardiovascular magnetic resonance Journal of the American College of Cardiology 51 1369 1374 10.1016/j.jacc.2007.11.071 18387438
31. MA Miller JA Gomes V Fuster 2007 Risk stratification of sudden cardiac death in hypertrophic cardiomyopathy Nat Clin Pract Cardiovasc Med 4 667 676 10.1038/ncpcardio1057 18033231 (Pubitemid 350162717)
32. J Gorcsan 3rd T Abraham DA Agler, et al. 2008 Echocardiography for cardiac resynchronization therapy: Recommendations for performance and reporting-A report from the American Society of Echocardiography Dyssynchrony Writing Group endorsed by the Heart Rhythm Society Journal of the American Society of Echocardiography 21 191 213 10.1016/j.echo.2008.01.003 18314047 (Pubitemid 351308105)
33. A D'Andrea P Caso S Severino, et al. 2006 Prognostic value of intra-left ventricular electromechanical asynchrony in patients with hypertrophic cardiomyopathy European Heart Journal 27 1311 1318 10.1093/eurheartj/ehi688 16364972 (Pubitemid 43998104)
34. BJ Maron I Olivotto P Spirito, et al. 2000 Epidemiology of hypertrophic cardiomyopathy-related death: revisited in a large non-referral-based patient population Circulation 102 858 864 1:STN:280:DC%2BD3cvhvFWhuw%3D%3D 10952953
35. A D'Andrea P Caso S Severino, et al. 2005 Association between intraventricular myocardial systolic dyssynchrony and ventricular arrhythmias in patients with hypertrophic cardiomyopathy Echocardiography 22 571 578 10.1111/j.1540-8175.2005.40073.x 16060893 (Pubitemid 41603163)
36. T Nagakura M Takeuchi H Yoshitani, et al. 2007 Hypertrophic cardiomyopathy is associated with more severe left ventricular dyssynchrony than is hypertensive left ventricular hypertrophy Echocardiography 24 677 684 10.1111/j.1540-8175.2007.00458.x 17651095 (Pubitemid 47094227)
37. TS Kato H Izawa K Komamura, et al. 2008 Heterogeneity of regional systolic function detected by tissue Doppler imaging is linked to impaired global left ventricular relaxation in hypertrophic cardiomyopathy Heart 94 1302 1306 10.1136/hrt.2007.124453 1:STN:280:DC%2BD1cnhtFenuw%3D%3D 18198205
38. JG Cleland JC Daubert E Erdmann, et al. 2005 The effect of cardiac resynchronization on morbidity and mortality in heart failure New England Journal of Medicine 352 1539 1549 10.1056/NEJMoa050496 1:CAS:528: DC%2BD2MXjtFGnsLo%3D 15753115 (Pubitemid 40517094)
39. JE Sanderson 2009 Echocardiography for cardiac resynchronization therapy selection: fatally flawed or misjudged? Journal of the American College of Cardiology 53 1960 1964 10.1016/j.jacc.2008.12.071 19460608
40. MS Maron I Olivotto BJ Maron, et al. 2009 The case for myocardial ischemia in hypertrophic cardiomyopathy Journal of the American College of Cardiology 54 866 875 10.1016/j.jacc.2009.04.072 19695469
41. BJ Maron JK Wolfson SE Epstein WC Roberts 1986 Intramural ("small vessel") coronary artery disease in hypertrophic cardiomyopathy Journal of the American College of Cardiology 8 545 557 1:STN:280:DyaL28zgsFChtA%3D%3D 3745699
42. C Basso G Thiene D Corrado G Buja P Melacini A Nava 2000 Hypertrophic cardiomyopathy and sudden death in the young: pathologic evidence of myocardial ischemia Human Pathology 31 988 998 10.1053/hupa.2000.16659 1:STN:280: DC%2BD3cvlvVWltQ%3D%3D 10987261 (Pubitemid 30672621)
43. F Cecchi I Olivotto R Gistri R Lorenzoni G Chiriatti PG Camici 2003 Coronary microvascular dysfunction and prognosis in hypertrophic cardiomyopathy New England Journal of Medicine 349 1027 1035 10.1056/NEJMoa025050 1:CAS:528:DC%2BD3sXntlagtbc%3D 12968086 (Pubitemid 37087617)
44. D Pitcher R Wainwright M Maisey P Curry E Sowton 1980 Assessment of chest pain in hypertrophic cardiomyopathy using exercise thallium-201 myocardial scintigraphy British Heart Journal 44 650 656 10.1136/hrt.44.6.650 1:STN:280:DyaL3M7htVWnug%3D%3D 7193039
45. PG Camici F Crea 2007 Coronary microvascular dysfunction New England Journal of Medicine 356 830 840 10.1056/NEJMra061889 1:CAS:528: DC%2BD2sXhvFKltLY%3D 17314342 (Pubitemid 46306100)
46. RO Cannon 3rd V Dilsizian PT O'Gara, et al. 1991 Myocardial metabolic, hemodynamic, and electrocardiographic significance of reversible thallium-201 abnormalities in hypertrophic cardiomyopathy Circulation 83 1660 1667 2022023
47. M Grover-McKay M Schwaiger J Krivokapich JK Perloff ME Phelps HR Schelbert 1989 Regional myocardial blood flow and metabolism at rest in mildly symptomatic patients with hypertrophic cardiomyopathy Journal of the American College of Cardiology 13 317 324 1:STN:280:DyaL1M7gvFyntQ%3D%3D 2783595
48. L Choudhury SD Rosen D Patel P Nihoyannopoulos PG Camici 1997 Coronary vasodilator reserve in primary and secondary left ventricular hypertrophy. A study with positron emission tomography European Heart Journal 18 108 116 1:STN:280:DyaK2s3gtF2ruw%3D%3D 9049522
49. N Kawada H Sakuma T Yamakado, et al. 1999 Hypertrophic cardiomyopathy: MR measurement of coronary blood flow and vasodilator flow reserve in patients and healthy subjects Radiology 211 129 135 1:STN:280:DyaK1M3gsFClsg%3D%3D 10189462
50. J Radvan L Choudhury DJ Sheridan PG Camici 1997 Comparison of coronary vasodilator reserve in elite rowing athletes versus hypertrophic cardiomyopathy American Journal of Cardiology 80 1621 1623 10.1016/S0002-9149(97)00778-9 1:STN:280:DyaK1c%2FnslCgtw%3D%3D 9416953 (Pubitemid 28011848)
51. S Sharma PM Elliott G Whyte, et al. 2000 Utility of metabolic exercise testing in distinguishing hypertrophic cardiomyopathy from physiologic left ventricular hypertrophy in athletes Journal of the American College of Cardiology 36 864 870 10.1016/S0735-1097(00)00816-0 1:STN:280: DC%2BD3cvlvV2msQ%3D%3D 10987612 (Pubitemid 30681611)
52. F Sardanelli G Molinari A Petillo, et al. 1993 MRI in hypertrophic cardiomyopathy: A morphofunctional study Journal of Computer Assisted Tomography 17 862 872 10.1097/00004728-199311000-00005 1:STN:280:DyaK2c%2FksVSjtg%3D%3D 8227570
53. C Rickers NM Wilke M Jerosch-Herold, et al. 2005 Utility of cardiac magnetic resonance imaging in the diagnosis of hypertrophic cardiomyopathy Circulation 112 855 861 10.1161/CIRCULATIONAHA.104.507723 16087809 (Pubitemid 41170072)
54. JC Moon NG Fisher WJ McKenna DJ Pennell 2004 Detection of apical hypertrophic cardiomyopathy by cardiovascular magnetic resonance in patients with non-diagnostic echocardiography Heart 90 645 649 10.1136/hrt.2003.014969 1:STN:280:DC%2BD2c3kslSisg%3D%3D 15145868
55. EA Zerhouni DM Parish WJ Rogers A Yang EP Shapiro 1988 Human heart: Tagging with MR imaging-A method for noninvasive assessment of myocardial motion Radiology 169 59 63 1:STN:280:DyaL1czjs1CktA%3D%3D 3420283
56. T Kuribayashi WC Roberts 1992 Myocardial disarray at junction of ventricular septum and left and right ventricular free walls in hypertrophic cardiomyopathy American Journal of Cardiology 70 1333 1340 10.1016/0002-9149(92) 90771-P 1:STN:280:DyaK3s%2FntFOgsw%3D%3D 1442587
57. MK Heng RF Janz J Jobin 1985 Estimation of regional stress in the left ventricular septum and free wall: An echocardiographic study suggesting a mechanism for asymmetric septal hypertrophy American Heart Journal 110 84 90 10.1016/0002-8703(85)90519-8 1:STN:280:DyaL2M3kvVWgsg%3D%3D 3160227 (Pubitemid 16119685)
58. JA Lima RM Judd A Bazille SP Schulman E Atalar EA Zerhouni 1995 Regional heterogeneity of human myocardial infarcts demonstrated by contrast-enhanced MRI. Potential mechanisms Circulation 92 1117 1125 1:STN:280: DyaK2Mzns1OntQ%3D%3D 7648655
59. E Wu RM Judd JD Vargas FJ Klocke RO Bonow RJ Kim 2001 Visualisation of presence, location, and transmural extent of healed Q-wave and non-Q-wave myocardial infarction Lancet 357 21 28 10.1016/S0140-6736(00)03567-4 1:STN:280:DC%2BD3M7gtV2huw%3D%3D 11197356 (Pubitemid 32056497)
60. V Roldan F Marin JR Gimeno, et al. 2008 Matrix metalloproteinases and tissue remodeling in hypertrophic cardiomyopathy American Heart Journal 156 85 91 10.1016/j.ahj.2008.01.035 1:CAS:528:DC%2BD1cXnvVGks7g%3D 18585501 (Pubitemid 351862294)
61. A Esposito F De Cobelli G Perseghin, et al. 2009 Impaired left ventricular energy metabolism in patients with hypertrophic cardiomyopathy is related to the extension of fibrosis at delayed gadolinium-enhanced magnetic resonance imaging Heart 95 228 233 10.1136/hrt.2008.142562 1:STN:280: DC%2BD1M%2FntVCnsQ%3D%3D 18708417
62. L Choudhury H Mahrholdt A Wagner, et al. 2002 Myocardial scarring in asymptomatic or mildly symptomatic patients with hypertrophic cardiomyopathy Journal of the American College of Cardiology 40 2156 2164 10.1016/S0735- 1097(02)02602-5 12505229 (Pubitemid 36005903)
63. K Debl B Djavidani S Buchner, et al. 2006 Delayed hyperenhancement in magnetic resonance imaging of left ventricular hypertrophy caused by aortic stenosis and hypertrophic cardiomyopathy: Visualisation of focal fibrosis Heart 92 1447 1451 10.1136/hrt.2005.079392 1:STN:280:DC%2BD28rkvVWhuw%3D%3D 16606864 (Pubitemid 44578839)
64. T Suk C Edwards H Hart JP Christiansen 2008 Myocardial scar detected by contrast-enhanced cardiac magnetic resonance imaging is associated with ventricular tachycardia in hypertrophic cardiomyopathy patients Heart Lung Circ 17 370 374 10.1016/j.hlc.2008.03.080 18562248
65. Jung, W. I., Sieverding, L., Breuer, J., et al. (2000). 31P NMR spectroscopy detects metabolic abnormalities in asymptomatic patients with hypertrophic cardiomyopathy. Circulation, 101(12), E121. PMID: 9657474.
66. de Roos A., Doornbos, J., Luyten, P. R., Oosterwaal, L. J., van der Wall, E. E., & den Hollander, J. (1992). Cardiac metabolism in patients with dilated and hypertrophic cardiomyopathy: assessment with proton-decoupled P-31 MR spectroscopy. Journal of Magnetic Resonance Imaging, 2(6), 711-9. PMID: 1446116.
67. MJ Blackledge B Rajagopalan RD Oberhaensli NM Bolas P Styles GK Radda 1987 Quantitative studies of human cardiac metabolism by 31P rotating-frame NMR Proceedings of the National Academy of Sciences of the United States of America 84 4283 4287 10.1073/pnas.84.12.4283 1:CAS:528:DyaL2sXksFGisL0%3D 3473502 (Pubitemid 17090918)
68. S Neubauer M Horn M Cramer, et al. 1997 Myocardial phosphocreatine-to-ATP ratio is a predictor of mortality in patients with dilated cardiomyopathy Circulation 96 2190 2196 1:CAS:528:DyaK2sXmvVKrsrs%3D 9337189
69. Shivu, G. N., Abozguia, K., Phan, T. T., Ahmed, I., Henning, A., & Frenneaux, M. (2008). (31)P magnetic resonance spectroscopy to measure in vivo cardiac energetics in normal myocardium and hypertrophic cardiomyopathy: Experiences at 3T. European Journal of Radiology, Dec. 2 [Epub ahead of print].
70. L Sieverding WI Jung J Breuer, et al. 1997 Proton-decoupled myocardial 31P NMR spectroscopy reveals decreased PCr/Pi in patients with severe hypertrophic cardiomyopathy American Journal of Cardiology 80 34A 40A 10.1016/S0002-9149(97)00456-6 1:STN:280:DyaK2svjvVWkuw%3D%3D 9293954 (Pubitemid 27377474)
71. L Thet Thet T Takeda J Wu, et al. 2003 Enhanced washout of 99mTc-tetrofosmin in hypertrophic cardiomyopathy: Quantitative comparisons with regional 123I-BMIPP uptake and wall thickness determined by MRI European Journal of Nuclear Medicine and Molecular Imaging 30 966 973 10.1007/s00259-003-1163-8 (Pubitemid 37086938)
72. DC Lefroy R de Silva L Choudhury, et al. 1993 Diffuse reduction of myocardial beta-adrenoceptors in hypertrophic cardiomyopathy: A study with positron emission tomography Journal of the American College of Cardiology 22 1653 1660 1:STN:280:DyaK2c%2FksVartQ%3D%3D 8227834